Cargando…

Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk

PURPOSE: To explore another choice for a controlled ovarian stimulation (COS) protocol that does not increase severe ovarian hyperstimulation syndrome (OHSS) risk among polycystic ovarian syndrome (PCOS) patients with specific clinical features. METHODS: A retrospective study was performed. Two hund...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Rui, Liao, Xin, Huang, Wanrong, Zeng, Rujun, Qin, Lang, Bai, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232123/ https://www.ncbi.nlm.nih.gov/pubmed/35757417 http://dx.doi.org/10.3389/fendo.2022.905263

Ejemplares similares

Determination of Half-lives of Circulating FSH and LH Glycoforms in Women During GnRH Receptor Blockade
por: Wide, Leif, et al.
Publicado: (2022)

A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF
por: Friis Petersen, J, et al.
Publicado: (2019)

The Effect of Photoperiodic Conditions on GnRH/LH Secretion in Ewes
por: Kopycińska, Kamila, et al.
Publicado: (2022)

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS
por: Yanagihara, Yasuho, et al.
Publicado: (2021)

The Role of GnRH Receptor Autoantibodies in Polycystic Ovary Syndrome
por: Kem, David C, et al.
Publicado: (2020)

Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
por: Xing, Weijie, et al.
Publicado: (2015)

Targeting Elevated GnRH Pulsatility to Treat Polycystic Ovary Syndrome
por: Abbara, Ali, et al.
Publicado: (2021)

Using Aptamers as a Novel Method for Determining GnRH/LH Pulsatility
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2020)

ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
por: Mokhtar, Sara, et al.
Publicado: (2015)

Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study
por: Lainas, George T, et al.
Publicado: (2012)

Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles
por: Choi, Min Hye, et al.
Publicado: (2012)

Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism
por: Malone, Samuel Andrew, et al.
Publicado: (2019)

Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study
por: Franco, José G, et al.
Publicado: (2009)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
por: Cho-Clark, Madelaine J., et al.
Publicado: (2023)

Is early-follicular long-acting GnRH agonist protocol an alternative for patients with polycystic ovary syndrome undergoing in vitro fertilization?
por: Wang, Di, et al.
Publicado: (2022)

Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2015)

Melatonin Inhibits GnRH-1, GnRH-3 and GnRH Receptor Expression in the Brain of the European Sea Bass, Dicentrarchus labrax
por: Servili, Arianna, et al.
Publicado: (2013)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023)

A mathematical model for LH release in response to continuous and pulsatile exposure of gonadotrophs to GnRH
por: Washington, Talitha M, et al.
Publicado: (2004)

A Two-Pathway Mathematical Model of the LH Response to GnRH that Predicts Self-Priming
por: Evans, J. J., et al.
Publicado: (2013)

Comparison of two different starting dose of rhFSH in GnRH antagonist protocol for patients with normal ovarian reserve
por: Jia, Zhi-cheng, et al.
Publicado: (2023)

A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
por: Chen, Ming-Jer, et al.
Publicado: (2022)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)

GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors
por: Sperduti, Samantha, et al.
Publicado: (2019)

Peripheral Inhibitor of AChE, Neostigmine, Prevents the Inflammatory Dependent Suppression of GnRH/LH Secretion during the Follicular Phase of the Estrous Cycle
por: Herman, Andrzej P., et al.
Publicado: (2017)

Effect of Central Injection of Neostigmine on the Bacterial Endotoxin Induced Suppression of GnRH/LH Secretion in Ewes during the Follicular Phase of the Estrous Cycle
por: Herman, Andrzej Przemysław, et al.
Publicado: (2019)

Elevated activity levels of activating autoantibodies to the GnRH receptor in patients with polycystic ovary syndrome
por: Weedin, Elizabeth A., et al.
Publicado: (2020)

FRI284 The GnRH Pulse Generator Activity In Mouse Models Of Polycystic Ovary Syndrome
por: Zhou, Ziyue, et al.
Publicado: (2023)

Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF/ICSI
por: Kim, Chung-Hoon, et al.
Publicado: (2012)

Eel Kisspeptins: Identification, Functional Activity, and Inhibition on both Pituitary LH and GnRH Receptor Expression
por: Pasquier, Jérémy, et al.
Publicado: (2018)

The value of LH maximum level in predicting optimal oocyte yield following GnRH agonist trigger
por: Lee, William Hao-Yu, et al.
Publicado: (2023)

Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis
por: Kadoura, Sally, et al.
Publicado: (2022)

Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study
por: Gui, Juan, et al.
Publicado: (2022)

Corrigendum: A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
por: Chen, Ming-Jer, et al.
Publicado: (2022)

Differential Roles of GnRH-I and GnRH-II Neurons in the Control of the Primate Reproductive Axis
por: Urbanski, Henry F.
Publicado: (2012)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

Comparacion de la fertilidad con dos protocolos: utilizando GnRH-PGF2a-GnRH y GnRH-PGF2a-estrogenos
por: Santiago Domínguez, Cesar
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9ghr2745u43cuckncpg829hi21